Apoorva Mandavilli
Posts
New C.D.C. Guidelines Suggest 70 Percent of Americans Can Stop Wearing Masks
The agency issued a new set of recommendations intended to help communities live with the virus and get back to normal life.
The Next Vaccine Debate: Immunize Young Children Now, or Wait?
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
The Next Vaccine Debate: Immunize Young Children Now, or Wait?
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
Younger Americans Benefited Less From Booster Shots Than Older People
Among those under age 50, vaccination even without a booster protected strongly against hospitalization and death, according to new C.D.C. data.
The Covid Vaccine We Need Now May Not Be a Shot
Nasal vaccines under development around the world may make better boosters by stopping the coronavirus in the airways.
Yes, Omicron Is Loosening Its Hold. But the Pandemic Has Not Ended.
With spotty immunity in the population and a churn of new variants, the coronavirus is likely to become a persistent but hopefully manageable threat.
As Omicron Crests, Booster Shots Are Keeping Americans Out of Hospitals
Extra vaccine doses were expected to lower infection rates. But the shots also seem to be preventing severe illness caused by the new variant, the...
The C.D.C.’s New Challenge? Grappling With Imperfect Science
The Omicron coronavirus variant is moving much faster than researchers can, worsening a longstanding problem: The agency must make tough decisions with scant data.
The C.D.C.’s New Challenge? Grappling With Imperfect Science
The Omicron coronavirus variant is moving much faster than researchers can, worsening a longstanding problem: The agency must make tough decisions with scant data.
Will ‘Forever Boosting’ Beat the Coronavirus?
Everyone should get a booster shot. In the long run, though, doses every few months aren’t a viable public health strategy, scientists say.